Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Time to resumption of spontaneous respiration with suxamethonium vs rocuronium + sugammadex
2009-010840-33Phase 4Completed
- Sponsor
- Belfast Health and Social Care Trust
- Start
- Apr 2009
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of succinylcholine, rocuronium and Sugammadex (2 arms), sponsored by Belfast Health and Social Care Trust. Primary endpoint: Time to resumption of spontaneous ventilation. Started Apr 2009; status: completed.
02
Drugs
succinylcholinerocuroniumSugammadex
Beyond the preview
Go deeper on 2009-010840-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010840-33.